Psychedelic drug
Pharmaceutical compound
4-Acetoxy-N ,N -dimethyltryptamine (4-AcO-DMT or4-acetoxy-DMT ), also known asO -acetylpsilocinpsilacetin , is apsychedelic drug of thetryptamine family related topsilocybin andpsilocin .[ 4] [ 5] [ 6] [ 7] synthetic derivative of psilocin (4-HO-DMT) in which thehydroxyl group has beenacetylated , and is theanalogue of psilocybin (4-PO-DMT) in which thephosphate ester has been replaced with an acetateester .[ 4] [ 5] [ 6] prodrug of psilocin and is usedorally similarly to psilocybin.[ 4] [ 5] [ 8] [ 1] [ 2]
As a prodrug of psilocin, 4-AcO-DMT acts as anon-selective serotonin receptor agonist , including of theserotonin 5-HT2A receptor .[ 4] [ 9] hallucinogenic effects of psilocin are thought to be mediated by activation of this receptor, although otherreceptors also contribute to its effects.[ 10] [ 11] [ 4] psilocybin mushrooms .[ 5] [ 8] [ 4] side effects such asnausea andbody load that can be caused by ingestion of whole psilocybin mushrooms.[ 5] [ 8] [ 4] onset and shorterduration than psilocybin.[ 8] safety .[ 4] potent by weight than psilocybin in animals when they are given atequimolar doses.[ 5]
4-AcO-DMT was first described in apatent byAlbert Hofmann in 1963 and itschemical synthesis was improved byDavid E. Nichols and colleagues in 1999.[ 5] [ 9] [ 6] scientific research , as the synthesis of psilocybin is more challenging and as psilocybin is acontrolled substance .[ 5] [ 9] [ 6] designer drug inEurope in 2009.[ 9] recreational drug in the 2010s and has been the most commonly used novel tryptamine.[ 5] [ 8] mushroom edibles in theUnited States as an alternative to psilocybin.[ 12] [ 13] [ 14] [ 15] synthetic shrooms ".[ 7] Amanita muscaria bath salts , and have been linked topoisonings and deaths.[ 16] [ 7] [ 15] [ 12]
4-AcO-DMT is not scheduled under United States law or any international drug schedules, including theUnited Nations 1971Convention on Psychotropic Substances , making it a potentially more accessible alternative to psilocybin for research.[ 5] in vivo is illegal and violates theFederal Analogue Act .[ 4]
In his bookTiHKAL Tryptamines I Have Known and Loved ),Alexander Shulgin lists the same dose range of 10 to 20 mg orally andduration of 3 to 6 hours for psilocin, psilocybin, and 4-AcO-DMT.[ 1] mg orally, with a typical dose of 12.5 mg orally, and a duration of about 5 to 8 hours.[ 2] mg orally, anonset of 15 to 40 minutes, and a duration of 4 to 7 hours.[ 3] prodrug of psilocin similarly topsilocybin and its effects are reported to be similar or identical to those of psilocybin andpsilocybin-containing mushrooms .[ 5] [ 8] [ 3] nausea andbody load than psilocybin-containing mushrooms.[ 5] [ 8] [ 4] onset and shorterduration than psilocybin.[ 8] potent by weight than psilocybin in animals when they are given atequimolar doses.[ 5]
Specific effects of 4-AcO-DMT have been reported to includepsychedelic visuals ,closed-eye imagery ,synesthesia ,insights , disembodiment,euphoria , feelings of bliss and unity,oceanic boundlessness ,ego dissolution ,sedation ,cognitive impairment , andspiritual experiences , among others.[ 2] [ 3] Adverse effects have been reported to includepsychological side effects such asanxiety ,paranoia , andlow mood as well asgastrointestinal side effects such asnausea andvomiting .[ 2]
4-AcO-DMT, as aprodrug of psilocin, is not expected to differ frompsilocybin orpsilocin in terms ofsafety .[ 4]
Psilocin at molecular targetsTarget Affinity (Ki , nM) 5-HT1A 49–567 (Ki )EC50 Tooltip half-maximal effective concentration )Emax Tooltip maximal efficacy ) 5-HT1B 31–305 5-HT1D 19–36 5-HT1E 44–52 5-HT1F ND 5-HT2A 6.0–340 (Ki )EC50 ) Emax ) 5-HT2B 4.6–410 (Ki )EC50 ) Emax ) 5-HT2C 10–141 (Ki )EC50 ) Emax ) 5-HT3 >10,000 5-HT4 ND 5-HT5A 70–84 5-HT6 57–72 5-HT7 3.5–72 α1A –α1B >10,000 α2A 1,379–2,044 α2B 1,271–1,894 α2C 4,404 β1 –β2 >10,000 D1 20–>14,000 D2 3,700–>10,000 D3 101–8,900 D4 >10,000 D5 >10,000 H1 1,600–>10,000 H2 –H4 >10,000 M1 –M5 >10,000 σ1 >10,000 σ2 >10,000 I2 792 TAAR1 1,400 (Ki ) (rat)i ) (mouse)EC50 ) (rodent) EC50 ) (human) SERT Tooltip Serotonin transporter 3,650–>10,000 (Ki )IC50 Tooltip half-maximal inhibitory concentration )EC50 ) Emax ) NET Tooltip Norepinephrine transporter 13,000 (Ki )IC50 ) EC50 ) DAT Tooltip Dopamine transporter 6,000–>30,000 (Ki )IC50 ) EC50 ) Notes: The smaller the value, the more avidly psilocin interacts with the site.Sources: [ 17] [ 18] [ 19] [ 20] [ 21] [ 22] [ 23] [ 24] [ 25] [ 26] [ 27] [ 28] [ 29] [ 30] [ 31] [ 32] [ 33] [ 34] [ 35]
4-AcO-DMT is aprodrug ofpsilocin (4-HO-DMT).[ 5] non-selective agonist ofserotonin receptors , including of theserotonin 5-HT2A receptor .[ 4] psychedelic effects of 4-AcO-DMT are mediated specifically by activation of the serotonin 5-HT2A receptor.[ 4]
Similarly topsilocybin , psilocin, and otherserotonergic psychedelics , 4-AcO-DMT produces thehead-twitch response , a behavioral proxy of psychedelic effects, in rodents.[ 5] [ 9] [ 7] [ 36] DOM in rodentdrug discrimination tests.[ 37] hypolocomotion andhypothermia in rodents as with psilocin as well.[ 5]
There are noclinical studies of thepharmacokinetics of 4-AcO-DMT as of 2024.[ 5] pharmacokinetics of 4-AcO-DMT have been studied in rodents.[ 5] prodrug ofpsilocin similarly topsilocybin (4-PO-DMT).[ 5] intraperitoneal injection atequimolar doses, 4-AcO-DMT showed only 70% of therelative bioavailability ortotal exposure of psilocybin.[ 5] molecular weight .[ 5] minutes after administration were 75 to 90% of those of an equimolar dose of psilocybin.[ 5] elimination half-life of psilocin was approximately 30 minutes and did not differ between 4-AcO-DMT and psilocybin.[ 5] ester prodrugs like 4-AcO-DMT arecleaved into psilocin byesterase enzymes .[ 38]
A 2025in-vitro [ 39] minutes under conditions mimicking the human body (i.e., in human plasma).[ 39] [ 39]
4-AcO-DMT shown in powder form. 4-AcO-DMT can be obtained byacetylation of psilocin underalkaline or stronglyacidic conditions. It is, therefore, asynthetic compound. 4-AcO-DMT is more resistant than psilocin to oxidation under basic conditions due to its acetoxy group. It is not as difficult as psilocybin to synthesize.[citation needed
Given enough time in unfavorable conditions, 4-AcO-DMT can sometimes turn into a degraded form which is brown in color and can even progress into a brown/black tar-like substance. Researchers hypothesize this is a polymerization reaction and is said to have no effect on thepotency of the substance. PreliminaryGCMS analysis of the closely relatedhomologue 4-AcO-DET suggests that this degraded form of 4-AcO-DMT consists mainly of the hydroxy form of the parent molecule.[ 40]
4-AcO-DMT is closely related topsilocin (4-HO-DMT) andpsilocybin (4-PO-DMT).[ 1] homologue of4-AcO-MET ,4-AcO-DET ,4-AcO-MiPT , and4-AcO-DiPT .[ 1] analogues of 4-AcO-DMT include4-AcO-DPT ,4-MeO-DMT , and4-PrO-DMT (O -propionylpsilocin).[ 1] [ 41] prodrugs of psilocin besides 4-AcO-DMT, 4-PrO-DMT, and psilocybin includeCT-4201 ,EB-002 ,RE-109 (4-GO-DMT), andMSP-1014 .
4-AcO-DMT and several otheresters ofpsilocin werepatented on January 16, 1963 bySandoz viaAlbert Hofmann and Franz Troxler.[ 5] [ 9] [ 42] [ 43] chemical synthesis was improved byDavid E. Nichols and colleagues in 1999 and it was suggested as a more economical and accessible alternative topsilocybin for use inscientific research .[ 5] [ 9] [ 6] designer drug inEurope in 2009.[ 9] recreational drug in the 2010s and has been the most commonly used noveltryptamine .[ 5] [ 8] mushroom edibles in theUnited States as an alternative to psilocybin andpsilocybin-containing mushrooms .[ 12] [ 13] [ 14] [ 15]
Society and culture [ edit ] 4-AcO-DMT is not scheduled under any international drug schedules, including theUnited Nations 1971Convention on Psychotropic Substances , making it a potentially more accessible alternative to psilocybin for research.[ 44]
4-AcO-DMT can be considered an analog ofpsilocin making it a Schedule 9 prohibited substance inAustralia under thePoisons Standard (October 2015).[ 45] [ 45]
4-AcO-DMT is not acontrolled substance inCanada as of 2025.[ 46]
4-AcO-DMT is prohibited inCzech Republic except strictly limited research and therapeutical purposes.[ 47]
4-AcO-DMT is banned inGermany according to theBtMG since it is an ester of psilocin.[ 48]
4-AcO-DMT is technically illegal inIsrael as of being a derivative ofdimethyltryptamine (DMT).[citation needed
4-AcO-DMT is illegal inItaly as it is anester of a prohibited substance.[citation needed
The Riksdag added 4-AcO-DMT toNarcotic Drugs Punishments Act underswedish schedule I ("substances, plant materials and fungi which normally do not have medical use" ) as of January 25, 2017, published byMedical Products Agency (MPA) in regulationHSLF-FS 2017:1 listed as "4-acetoxi-N ,N -dimetyltryptamin".[ 49]
4-AcO-DMT, being an ester of psilocin, is aClass A drug in theUnited Kingdom under theMisuse of Drugs Act 1971 .[ 50]
4-AcO-DMT is not an explicitlycontrolled substance in theUnited States .[ 51] [ 4] [ 52] psilocin andpsilocybin under theFederal Analogue Act , but only if intended or used for human consumption.[ 4] [ 52] [ 4] [ 52]
While not controlled at the federal level, 4-AcO-DMT is listed as a controlled substance at the state level in multiple states in the United States, including inAlabama which has made it a schedule I at the state level on March 18, 2014, along with several other tryptamine analogues.[ 53]
^a b c d e f g Shulgin A ,Shulgin A (September 1997).TiHKAL: The Continuation Berkeley, California :Transform Press .ISBN 0-9630096-9-9 OCLC 38503252 .https://www.erowid.org/library/books_online/tihkal/tihkal18.shtml ^a b c d e f Mallaroni P, Mason NL, Vinckenbosch FR, Ramaekers JG (June 2022)."The use patterns of novel psychedelics: experiential fingerprints of substituted phenethylamines, tryptamines and lysergamides" .Psychopharmacology (Berl) .239 (6):1783– 1796.doi :10.1007/s00213-022-06142-4 .PMC 9166850 PMID 35487983 . ^a b c d e f "4-AcO-DMT (Ацетилпсилоцин)" .АИПСИН (in Russian). Retrieved1 January 2026 .^a b c d e f g h i j k l m n o p Geiger HA, Wurst MG, Daniels RN (October 2018)."DARK Classics in Chemical Neuroscience: Psilocybin" (PDF) .ACS Chem Neurosci .9 (10):2438– 2447.doi :10.1021/acschemneuro.8b00186 .PMID 29956917 .A chemically modified psilocin precursor, known as psilacetin (20), O-acetylpsilocin, or 4-acetoxy-N,N-dimethyltryptamine, which replaces the phosphoryloxy group found on psilocybin with an acetoxy group, is also readily available. The substituted acetoxy group is believed to be metabolized in an equivalent manner to the phosphoryloxy group, both producing psilocin during first-pass metabolism.37 This simple modification skirts written laws in the United States when the product is clearly designated "not for human consumption," allowing pseudolegal import and possession for research purposes only; however, if it were to be used in vivo, the user would be in violation of the Federal Analogue Act.38 Although psilacetin has been hypothesized to act as an identical pharmacological substitute for psilocybin, many users report a small, yet significant, difference in the effects of each drug.39 Psilacetin is often described as having a faster onset of action without the anxiety and nausea associated with psilocybin-containing mushroom ingestion (which could be due to avoiding the ingestion of the significant amounts of chitin usually found in these mushrooms) and to have a shorter duration of action with a more peaceful experience throughout, leaving most users with a positive afterglow.37,39 ^a b c d e f g h i j k l m n o p q r s t u v w x y z Jones NT, Wagner L, Hahn MC, Scarlett CO, Wenthur CJ (2024)."In vivo validation of psilacetin as a prodrug yielding modestly lower peripheral psilocin exposure than psilocybin" .Front Psychiatry .14 1303365.doi :10.3389/fpsyt.2023.1303365 PMC 10804612 PMID 38264637 . ^a b c d e Nichols D, Fescas S (1999)."Improvements to the Synthesis of Psilocybin and a Facile Method for Preparing the O-Acetyl Prodrug of Psilocin" (PDF) .Synthesis .1999 (6):935– 938.CiteSeerX 10.1.1.690.8071 doi :10.1055/s-1999-3490 .S2CID 32044725 .Archived (PDF) from the original on 17 February 2012. Retrieved17 January 2012 . ^a b c d Wright W (24 June 2024)."4-AcO-DMT Is the Most Accessible (and Mysterious) Drug on the Market Right Now" .DoubleBlind Mag . Retrieved2 February 2025 . ^a b c d e f g h i Palamar JJ, Acosta P (January 2020)."A qualitative descriptive analysis of effects of psychedelic phenethylamines and tryptamines" .Human Psychopharmacology .35 (1) e2719.doi :10.1002/hup.2719 .PMC 6995261 PMID 31909513 .4-AcO-DMT (4-acetoxyN,N-dimethyltryptamine, O-acetylpsilocin, or psilacetin) was the most prevalent tryptamine reported with 30.8% of the sample reporting use and two thirds (66.7%) of tryptamine users reporting use. 4-AcO-DMT—often pronounced as "4-akko-DMT"—was reported by most users as producing similar effects as psilocybin mushrooms with less nausea. One participant referred to this compound as "silly pills," which is a play on the name psilocybin. This particular compound was often preferred over natural mushrooms due to the lack of adverse side effects such as nausea, which the natural mushroom tends to produce. Thus, participants often suggested that 4-AcODMT allows one to achieve the same high as psilocybin without adverse physical effects such as nausea and heavy body load. One participant did complain of dry mouth and mentioned that although 4-AcO-DMT feels similar to psilocybin, he said it lacks the "organic" feel produced by psilocybin. [...] Of the most common tryptamines used by this sample, the majority of these compounds were first discovered or first synthesized as early as the 1930s (e.g., 5-MeO-DMT), 1950s (e.g., 4-AcO-DMT), or in the 1970s (e.g., 4-HO-MET and 5-MeO-DIPT). [...] 4-AcO-DMT was the most commonly used tryptamine by participants, and this compound also appears to be among the most prevalent novel tryptamines in recent years (Palamar & Le, 2019; PalmaConesa et al., 2017). [...] 4-AcO-DMT is often described as having a faster onset of action than psilocybin with a high of shorter duration, and as many of our participants noted, use allows them to avoid the nausea commonly associated mushroom ingestion (Geiger et al., 2018). Despite 4-AcO-DMT being among the most prevalent tryptamines, and having been discovered in the 1950s, little academic research has focused on recreational use of this compound. ^a b c d e f g h Klein AK, Chatha M, Laskowski LJ, Anderson EI, Brandt SD, Chapman SJ, et al. (April 2021)."Investigation of the Structure-Activity Relationships of Psilocybin Analogues" .ACS Pharmacol Transl Sci .4 (2):533– 542.doi :10.1021/acsptsci.0c00176 .PMC 8033608 PMID 33860183 . ^ Halberstadt AL (January 2015)."Recent advances in the neuropsychopharmacology of serotonergic hallucinogens" .Behav Brain Res .277 :99– 120.doi :10.1016/j.bbr.2014.07.016 .PMC 4642895 PMID 25036425 . ^ Kwan AC, Olson DE, Preller KH, Roth BL (November 2022)."The neural basis of psychedelic action" .Nat Neurosci .25 (11):1407– 1419.doi :10.1038/s41593-022-01177-4 .PMC 9641582 PMID 36280799 . ^a b c Blakinger K, Sheets C (9 August 2024)."Magic mushroom chocolates are having a moment. But do they even contain mushrooms?" .Los Angeles Times . Retrieved1 February 2025 . ^a b Ovalle D (4 July 2024)."Psychedelic mushroom edibles promise health benefits. Be wary, experts say" .Washington Post . Archived fromthe original on 4 July 2024. Retrieved1 February 2025 . ^a b Syal A (18 July 2024)."Mushroom edibles are rising in popularity. It's hard to say what's in them" .NBC News . Retrieved1 February 2025 . ^a b c Ducharme J (4 October 2024)."Are Mushroom Edibles Safe and Legal?" .TIME . Retrieved1 February 2025 . ^ Mole B (5 July 2024)."What we know about microdosing candy illnesses as death investigation underway" .Ars Technica . Retrieved1 February 2025 . ^ Liu T."BindingDB BDBM50081701 3-[2-(dimethylamino)ethyl]-1H-indol-4-ol::4-hydroxy-N,N-dimethyltryptamine::CHEMBL65547::N,N-dimethyl-4-hydroxytryptamine::Psilocin::US11427604, Compound (I-45)::US11453689, Compound Psilocin::US11591353, Compound I-45::US11597738, Example 3::US11642336, Compound Psilocin::US20240051978, Compound Psilocin" .BindingDB . Retrieved5 September 2024 . ^ Liu T."BindingDB BDBM50171269 3-[2-(dimethylamino)ethyl]-1H-indol-4-yl dihydrogen phosphate::4-phosphoryloxy-N,N-dimethyltryptamine::CHEMBL194378::Indocybin::O-phosphoryl-4-hydroxy-N,N-dimethyltryptamine::Psilocybine::US11597738, Example 4::psilocin phosphate ester::psilocybin" .BindingDB . Retrieved5 September 2024 . ^ "PDSP Database" .UNC (in Zulu). Retrieved2024-09-05 .^ "PDSP Database" .UNC (in Zulu). Retrieved2024-09-05 .^ Holze F, Singh N, Liechti ME, D'Souza DC (May 2024)."Serotonergic Psychedelics: A Comparative Review of Efficacy, Safety, Pharmacokinetics, and Binding Profile" .Biol Psychiatry Cogn Neurosci Neuroimaging .9 (5):472– 489.doi :10.1016/j.bpsc.2024.01.007 PMID 38301886 . ^ Dodd S, Norman TR, Eyre HA, Stahl SM, Phillips A, Carvalho AF, et al. (August 2023)."Psilocybin in neuropsychiatry: a review of its pharmacology, safety, and efficacy" (PDF) .CNS Spectr .28 (4):416– 426.doi :10.1017/S1092852922000888 .PMID 35811423 . ^ Tylš F, Páleníček T, Horáček J (March 2014)."Psilocybin - summary of knowledge and new perspectives" .Eur Neuropsychopharmacol .24 (3):342– 356.doi :10.1016/j.euroneuro.2013.12.006 .PMID 24444771 . ^ Wojtas A, Gołembiowska K (December 2023)."Molecular and Medical Aspects of Psychedelics" .Int J Mol Sci .25 (1): 241.doi :10.3390/ijms25010241 PMC 10778977 PMID 38203411 . ^ Rickli A, Moning OD, Hoener MC, Liechti ME (August 2016)."Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens" (PDF) .Eur Neuropsychopharmacol .26 (8):1327– 1337.doi :10.1016/j.euroneuro.2016.05.001 .PMID 27216487 . ^ Ray TS (February 2010)."Psychedelics and the human receptorome" .PLOS ONE .5 (2) e9019.Bibcode :2010PLoSO...5.9019R .doi :10.1371/journal.pone.0009019 PMC 2814854 PMID 20126400 . ^ Plazas E, Faraone N (February 2023)."Indole Alkaloids from Psychoactive Mushrooms: Chemical and Pharmacological Potential as Psychotherapeutic Agents" .Biomedicines .11 (2): 461.doi :10.3390/biomedicines11020461 PMC 9953455 PMID 36830997 . ^ US 11440879 , Andrew Carry Kruegel, "Methods of treating mood disorders", published 10 February 2022, assigned to Gilgamesh Pharmaceuticals, Inc. ^ Rothman RB, Partilla JS, Baumann MH, Lightfoot-Siordia C, Blough BE (April 2012)."Studies of the biogenic amine transporters. 14. Identification of low-efficacy "partial" substrates for the biogenic amine transporters" .The Journal of Pharmacology and Experimental Therapeutics .341 (1):251– 262.doi :10.1124/jpet.111.188946 .PMC 3364510 PMID 22271821 . ^ Blough BE, Landavazo A, Decker AM, Partilla JS, Baumann MH, Rothman RB (October 2014)."Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes" .Psychopharmacology (Berl) .231 (21):4135– 4144.doi :10.1007/s00213-014-3557-7 .PMC 4194234 PMID 24800892 . ^ Marek GJ, Makai-Bölöni S, Umbricht D, Christian EP, Winters J, Dvorak D, et al. (October 2025). "A novel psychedelic 5-HT2A receptor agonist GM-2505: The pharmacokinetic, safety, and pharmacodynamic profile from a randomized trial healthy volunteer".J Psychopharmacol 2698811251378512.doi :10.1177/02698811251378512 .PMID 41099491 . ^ Wsół A (December 2023)."Cardiovascular safety of psychedelic medicine: current status and future directions" .Pharmacol Rep .75 (6):1362– 1380.doi :10.1007/s43440-023-00539-4 .PMC 10661823 PMID 37874530 . ^ Chen X, Li J, Yu L, Maule F, Chang L, Gallant JA, et al. (October 2023)."A cane toad (Rhinella marina) N-methyltransferase converts primary indolethylamines to tertiary psychedelic amines" .J Biol Chem .299 (10) 105231.doi :10.1016/j.jbc.2023.105231 .PMC 10570959 PMID 37690691 . ^ Chen X, Li J, Yu L, Dhananjaya D, Maule F, Cook S, et al. (10 March 2023),Bioproduction platform using a novel cane toad (Rhinella marina) N-methyltransferase for psychedelic-inspired drug discovery (PDF) ,doi :10.21203/rs.3.rs-2667175/v1 , retrieved18 March 2025 ^ Gainetdinov RR, Hoener MC, Berry MD (July 2018)."Trace Amines and Their Receptors" .Pharmacol Rev .70 (3):549– 620.doi :10.1124/pr.117.015305 PMID 29941461 . ^ Halberstadt AL, Geyer MA (2018). "Effect of Hallucinogens on Unconditioned Behavior".Behavioral Neurobiology of Psychedelic Drugs . Current Topics in Behavioral Neurosciences. Vol. 36. pp. 159– 199.doi :10.1007/7854_2016_466 .ISBN 978-3-662-55878-2 PMC 5787039 PMID 28224459 . ^ Gatch MB, Hoch A, Carbonaro TM (April 2021)."Discriminative Stimulus Effects of Substituted Tryptamines in Rats" .ACS Pharmacol Transl Sci .4 (2):467– 471.doi :10.1021/acsptsci.0c00173 .PMC 8033599 PMID 33860176 . ^ Raithatha SA, Hagel JM, Matinkhoo K, Yu L, Press D, Cook SG, et al. (January 2024)."Novel Psilocin Prodrugs with Altered Pharmacological Properties as Candidate Therapies for Treatment-Resistant Anxiety Disorders" .J Med Chem .67 (2):1024– 1043.doi :10.1021/acs.jmedchem.3c01225 .PMC 10823477 PMID 37983270 . ^a b c Eklund J, Bremberg U, Larsson J, Torkelsson E, Wennerberg J, Zandelin S, et al. (March 2025)."Synthesis and In Vitro Profiling of Psilocin Derivatives: Improved Stability and Synthetic Properties" .J Med Chem .68 (7):7153– 7165.doi :10.1021/acs.jmedchem.4c02612 PMC 11997985 PMID 40108981 . ^ "Erowid 4-Acetoxy-DET Vaults : 4-Acetoxy-DET / Ethacetin Degradation" .erowid.org . 4 July 2003. Retrieved10 September 2023 .^ Glatfelter GC, Naeem M, Pham DN, Golen JA, Chadeayne AR, Manke DR, et al. (April 2023)."Receptor Binding Profiles for Tryptamine Psychedelics and Effects of 4-Propionoxy-N,N-dimethyltryptamine in Mice" .ACS Pharmacol Transl Sci .6 (4):567– 577.doi :10.1021/acsptsci.2c00222 .PMC 10111620 PMID 37082754 . ^ US patent 3075992 , Hofmann A, Troxler F, "Esters of indoles", assigned to Sandoz Ltd. ^ US 3075992 ^ Jones NT, Wagner L, Hahn MC, Scarlett CO, Wenthur CJ (2024)."In vivo validation of psilacetin as a prodrug yielding modestly lower peripheral psilocin exposure than psilocybin" .Front Psychiatry .14 1303365.doi :10.3389/fpsyt.2023.1303365 PMC 10804612 PMID 38264637 . ^a b "Poisons Standard October 2015" .Federal Register of Legislation . Australian Government. 30 September 2015.Archived from the original on 2016-01-19. Retrieved2016-01-06 .^ "Controlled Drugs and Substances Act" .Department of Justice Canada . Retrieved19 January 2026 .^ "Government regulation of the list of the addictive substances" .Federal Register of Legislation . Czech Government.^ "Anlage I BtMG" .Einzelnorm (in German). Retrieved2024-11-21 .^ "Föreskrifter om ändring i Läkemedelsverkets föreskrifter (LVFS 2011:10) om förteckningar över narkotika" [Regulations on changes in the Swedish Medicines Agency's regulations (LVFS 2011:10) on lists of narcotics](PDF) (in Swedish).Archived (PDF) from the original on 2017-10-31. Retrieved2017-04-21 .^ Misuse of Drugs Act 1971 (Schedule 2 Part I). 1971.^ Orange Book: List of Controlled Substances and Regulated Chemicals (January 2026) (PDF) ,United States : U.S.Department of Justice :Drug Enforcement Administration (DEA): Diversion Control Division, January 2026^a b c Elliott SP, Holdbrook T, Brandt SD (May 2020). "Prodrugs of New Psychoactive Substances (NPS): A New Challenge".J Forensic Sci .65 (3):913– 920.doi :10.1111/1556-4029.14268 .PMID 31943218 .In a review about psilocybin, Geiger et al. (58) also discussed the modified psilocin precursor, O-acetylpsilocin (4-acetoxy-N,N-dimethyltryptamine also known as psilacetin) which is available for purchase online having been mentioned in drug forums and to a limited extent in the literature (59,60). Chemically, an acetoxy group replaces the phosphoryloxy group found on psilocybin and is believed to be metabolized to produce psilocin during first-pass metabolism (58). The authors report that this modification obfuscates written laws in the United States when the product is designated "not for human consumption," allowing pseudo-legal import and possession for research purposes only; however, if it were to be used in vivo, the user would be in violation of the Federal Analogue Act (58). ^ "Controlled Substances List" (PDF) .Alabama State Board of Health . 22 February 2024. p. 50. Archived fromthe original (PDF) on 8 August 2024. Retrieved18 August 2024 .
Tryptamines
No ring subs. 4-Hydroxytryptamines 5-Hydroxytryptamines 5-Methoxytryptamines Other ring subs. α-Alkyltryptamines Others Cyclized Ergolines /lysergamides (e.g.,LSD )Ibogalogs (e.g.,ibogainalog ,tabernanthalog )O -MethylnordehydrobufoteninePartial ergolines (e.g.,NDTDI ,RU-28306 ,CT-5252 )Piperidinylethylindoles (e.g.,pip-T )Pyrrolidinylethylindoles (e.g.,pyr-T ,5-MeO-pyr-T )Pyrrolidinylmethylindoles (e.g.,MPMI ,4-HO-MPMI (lucigenol) ,5-MeO-MPMI ,MSP-2020 )Tetrahydropyridinylindoles (e.g.,RU-28253 (5-MeO-THPI) ,NEtPhOH-THPI )Bioisosteres Benzofurans (e.g.,5-MeO-DiBF (1-oxa-5-MeO-DiPT) ,dimemebfe (5-MeO-BFE; 1-oxa-5-MeO-DMT) ,mebfap (5-MeO-3-APB; 1-oxa-5-MeO-AMT) )Benzothiophenes (e.g.,3-APBT (1-thia-AMT) )Indazolethylamines (e.g.,AL-38022A ,O -methyl-AL-34662Indenylethylamines (e.g.,C-DMT )Isotryptamines (e.g.,6-MeO-isoDMT ,Ro60-0175 )MYCO-005 Quinolinylethylamines (e.g.,mefloquine )
Phenethylamines
Scalines 2C-x Others: 2C-B-AN 2C-DB 2C-G-x (e.g.,2C-G-3 ,2C-G-5 )β-Keto-2C-B (βk-2C-B) β-Keto-2C-I (βk-2C-I) β-Methyl-2C-B (BMB) BOx BOB ,BOD ,BOHB )HOT-x HOT-2 ,HOT-7 ,HOT-17 )N -Ethyl-2C-BTWEETIOs 2CB-2-EtO ,2CD-2-EtO ,2CD-5-EtO ,2CE-5-EtO ,2CE-5iPrO ,2CT2-5-EtO ,ASR-2001 (2CB-5-PrO) )3C-x DOx 4C-x Ψ-PEA MDxx FLY 25x-NB (NBOMes) Others 25B-NAcPip 2-DM-DOM 4-HA 5-DM-DOM Benzofurans (e.g.,5-APB ,5-APDB ,6-APB ,6-APDB ,F ,F-2 ,F-22 )Benzothiophenes (e.g.,5-APBT ,6-APBT )CT-5172 DMAs (e.g.,2,4-DMA ,3,4-DMA )Fenfluramine MMA (3-MeO-4-MA) Norfenfluramine PEA-NDEPAs 25D-NM-NDEAOP ,DOB-NDEPA ,DOI-NDEPA ,DOM-NDEPA ,DOTFM-NDEPA ,M-NDEPA ,TMA-2-NDEPA )PMA (4-MA) Thio-2Cs (e.g.,2C-5-TOET )Thio-DOx (e.g.,2-TOM ,5-TOET ,5-TOM ,TOMSO )TMAs TMA-3 ,TMA-4 ,TMA-5 )ZDCM-04 (DOC-fenethylline) Cyclized 1-Aminomethylindanes (e.g.,2CB-Ind ,jimscaline )2-Aminoindanes (e.g.,DOM-AI )3-Benzazepines (e.g.,lorcaserin )3-Phenylpiperidines (e.g.,LPH-5 ,LPH-48 )Benzocyclobutenes (e.g.,2CBCB-NBOMe ,TCB-2 ,tomscaline )Benzoxepins (e.g.,BBOX ,IBOX ,TFMBOX )DMBMPP (juncosamine) Ergolines /lysergamides (e.g.,LSD )Glaucine Partial ergolines (e.g.,NDTDI ,DEIMDHPCA ,DEMPDHPCA ,DEMTMPDHPCA ,DEMNDHPCA )Phenylcyclopropylamines (e.g.,DMCPA ,TMT )Phenyloxazolamines (aminorexes ) (e.g.,2C-B-aminorex )Pyridopyrroloquinoxalines (e.g.,IHCH-7113 )Z3517967757 ZC-B
Lysergamides Others Arylpiperazines (e.g.,2C-B-PP ,2-NP ,mCPP ,MK-212 ,ORG-12962 ,pCPP ,pFPP ,quipazine ,TFMPP )Dihydrobenzoxazines (e.g.,efavirenz )Phenoxyethylamines (e.g.,CT-4719 ,ORG-37684 )Pyridopyrroloquinoxalines (e.g.,IHCH-7113 )Quinazolinylethylamines (e.g.,RH-34 )Natural sources Tryptamines: Acacia spp.Acacia acuminata Acacia confusa Ayahuasca andvinho de Jurema (e.g.,Psychotria viridis (chacruna)Dipolopterys cabrerana (chaliponga, chacruna)Mimosa tenuiflora (Mimosa hostilis ; jurema)Brosimum Brosimum acutifolium (takini)Hallucinogenic snuffs (e.g.,Anadenanthera peregrina (yopo, jopo, cohoba, parica, ebene)Anadenanthera colubrina (vilca, cebil)Incilius alvarius (Bufo alvarius ; Colorado River toad, Sonoran Desert toad; bufo)Psilocybin-containing mushrooms (magic mushrooms, shrooms) (e.g.,Psilocybe cubensis Psilocybe mexicana (teonanacatl)Lysergamides: Achnatherum robustum (sleepy grass)Epichloë spp.Ergot (Claviceps ) (e.g.,Claviceps purpurea Claviceps paspali Morning glory (Convolvulaceae) seeds (e.g.,Ipomoea tricolor (tlitliltzin, badoh negro;Ipomoea violacea )Ipomoea corymbosa (coaxihuitl, ololiúqui;Rivea Corymbosa ,Turbina Corymbosa )Argyreia nervosa (Hawaiian baby woodrose; HBWR)Periglandula spp.Periglandula ipomoeae Periglandula clandestina
5-HT1
5-HT1A
Agonists: 4-F-5-MeO-pyr-T 5-MeO-pip-T 5-MeO-pyr-T 8-OH-DPAT Adatanserin Amphetamine Antidepressants (e.g.,etoperidone ,hydroxynefazodone ,nefazodone ,trazodone ,triazoledione ,vilazodone ,vortioxetine )Atypical antipsychotics (e.g.,aripiprazole ,asenapine ,brexpiprazole ,cariprazine ,clozapine ,lurasidone ,quetiapine ,ziprasidone )Azapirones (e.g.,buspirone ,eptapirone (F-11440) ,gepirone ,perospirone ,tandospirone )Bay R 1531 Befiradol (NLX-112; F-13640) BMY-14802 Cannabidiol Dimemebfe Dopamine Ebalzotan Eltoprazine Enciprazine Ergolines (e.g.,bromocriptine ,cabergoline ,dihydroergotamine ,ergotamine ,lisuride ,LSD ,methylergometrine (methylergonovine) ,methysergide ,pergolide )F-11461 F-12826 F-13714 F-14679 F-15063 F-15599 (NLX-101) Flesinoxan Flibanserin Flumexadol Hypidone Lesopitron LY-293284 LY-301317 mCPP Naluzotan NBUMP NLX-204 NLX-266 Osemozotan (MKC-242) Oxaflozane Pardoprunox Piclozotan Rauwolscine Repinotan Roxindole RU-24969 S-14506 S-14671 S-15535 Sarizotan Serotonin (5-HT) SSR-181507 Sunepitron Tryptamines (e.g.,5-CT ,5-MeO-DMT ,5-MT ,bufotenin ,DMT ,indorenate ,N-Me-5-HT ,psilocin ,psilocybin )TGBA01AD TMU4142 U-92016-A Urapidil Vilazodone Xaliproden Yohimbine Antagonists: Atypical antipsychotics (e.g.,iloperidone ,risperidone ,sertindole )AV965 Beta blockers (e.g.,alprenolol ,carteolol ,cyanopindolol ,iodocyanopindolol ,isamoltane ,oxprenolol ,penbutolol ,pindobind ,pindolol ,propranolol ,tertatolol )BMY-7378 CSP-2503 Dotarizine Ergolines (e.g.,metergoline )FCE-24379 Flopropione GR-46611 Isamoltane Lecozotan Mefway Metitepine (methiothepin) MIN-117 (WF-516) MPPF NAN-190 Robalzotan S-15535 SB-649915 SDZ 216-525 Spiperone Spiramide Spiroxatrine UH-301 WAY-100135 WAY-100635 Xylamidine
5-HT1B
Agonists: Alniditan Anpirtoline AZ10419369 Benzofurans (e.g.,5-MAPB ,6-MAPB ,BK-5-MAPB ,BK-6-MAPB )Benzothiophenes (e.g.,5-MAPBT ,6-MAPBT ,BK-5-MAPBT )CGS-12066 (CGS-12066A, CGS-12066B) CP-93129 CP-94253 CP-122288 CP-135807 Eltoprazine Ergolines (e.g.,bromocriptine ,dihydroergotamine ,ergotamine ,methylergometrine (methylergonovine) ,methysergide ,pergolide )mCPP Methylenedioxyphenethylamines (e.g.,MDMA ,methylone )PGI-7043 PZKKN-94 RU-24969 Serotonin (5-HT) Triptans (e.g.,avitriptan ,donitriptan ,eletriptan ,IS-159 ,sumatriptan ,zolmitriptan )TFMPP Tryptamines (e.g.,5-BT ,5-CT ,5-MT ,DMT )Vortioxetine
5-HT1D
Agonists: Alniditan CGS-12066 (CGS-12066A, CGS-12066B) CP-122288 CP-135807 CP-286601 Ergolines (e.g.,bromocriptine ,cabergoline ,dihydroergotamine ,ergotamine ,LSD ,methysergide )GR-46611 L-694247 L-772405 mCPP PNU-109291 PNU-142633 Serotonin (5-HT) TGBA01AD Triptans (e.g.,almotriptan ,avitriptan ,donitriptan ,eletriptan ,frovatriptan ,IS-159 ,naratriptan ,rizatriptan ,sumatriptan ,zolmitriptan )Tryptamines (e.g.,5-BT ,5-CT ,5-Et-DMT ,5-MT ,5-(nonyloxy)tryptamine ,DMT )
5-HT1E
5-HT1F
5-HT2
5-HT2A
Agonists: 25H/NB series (e.g.,25I-NBF ,25I-NBMD ,25I-NBOH ,25I-NBOMe ,25B-NBOMe ,25C-NBOMe ,25TFM-NBOMe ,2CBCB-NBOMe ,25CN-NBOH ,2CBFly-NBOMe )2Cs (e.g.,2C-B ,2C-E ,2C-I ,2C-T-2 ,2C-T-7 ,2C-T-21 )2C-B-FLY 2CB-Ind 5-Methoxytryptamines (5-MeO-DET ,5-MeO-DiPT ,5-MeO-DMT ,5-MeO-DPT ,5-MT )α-Alkyltryptamines (e.g.,5-Cl-αMT ,5-Fl-αMT ,5-MeO-αET ,5-MeO-αMT ,α-Me-5-HT ,αET ,αMT )AL-34662 AL-37350A Bromo-DragonFLY Dimemebfe DMBMPP DOx (e.g.,DOB ,DOC ,DOI ,DOM )Efavirenz Ergolines (e.g.,1P-LSD ,ALD-52 ,bromocriptine ,cabergoline ,ergine (LSA) ,ergometrine (ergonovine) ,ergotamine ,lisuride ,LA-SS-Az ,LSB ,LSD ,LSD-Pip ,LSH ,LSP ,methylergometrine (methylergonovine) ,pergolide )Flumexadol IHCH-7113 Jimscaline Lorcaserin MDxx (e.g.,MDA (tenamfetamine) ,MDMA (midomafetamine) ,MDOH ,MMDA )O-4310 Oxaflozane PHA-57378 PNU-22394 PNU-181731 RH-34 SCHEMBL5334361 Phenethylamines (e.g.,lophophine ,mescaline )Piperazines (e.g.,BZP ,quipazine ,TFMPP )Serotonin (5-HT) TCB-2 TFMFly Tryptamines (e.g.,5-BT ,5-CT ,bufotenin ,DET ,DiPT ,DMT ,DPT ,psilocin ,psilocybin ,tryptamine )Antagonists: 5-I-R91150 5-MeO-NBpBrT AC-90179 Adatanserin Altanserin Antihistamines (e.g.,cyproheptadine ,hydroxyzine ,ketotifen ,perlapine )AMDA Atypical antipsychotics (e.g.,amperozide ,aripiprazole ,asenapine ,blonanserin ,brexpiprazole ,carpipramine ,clocapramine ,clorotepine ,clozapine ,fluperlapine ,gevotroline ,iloperidone ,lurasidone ,melperone ,mosapramine ,ocaperidone ,olanzapine ,paliperidone ,quetiapine ,risperidone ,sertindole ,zicronapine ,ziprasidone ,zotepine )Butanserin Chlorprothixene Cinanserin CSP-2503 Deramciclane Dotarizine Eplivanserin Ergolines (e.g.,amesergide ,LY-53857 ,LY-215840 ,mesulergine ,metergoline ,methysergide ,sergolexole )Fananserin Flibanserin Glemanserin Irindalone Ketanserin KML-010 Landipirdine LY03017 LY-393558 mCPP Medifoxamine Metitepine (methiothepin) Metrenperone MIN-117 (WF-516) MT-1207 Naftidrofuryl Nantenine Nelotanserin NH130 Opiranserin (VVZ-149) Pelanserin Phenoxybenzamine Pimavanserin Pirenperone Pizotifen Pruvanserin Rauwolscine Ritanserin Roluperidone S-14671 Sarpogrelate Seganserin Serotonin antagonists and reuptake inhibitors (e.g.,etoperidone ,hydroxynefazodone ,lubazodone ,mepiprazole ,nefazodone ,triazoledione ,trazodone )Temanogrel Teniloxazine Tetracyclic antidepressants (e.g.,amoxapine ,aptazapine ,esmirtazapine ,maprotiline ,mianserin ,mirtazapine )TGBA01AD Trelanserin Tricyclic antidepressants (e.g.,amitriptyline )Typical antipsychotics (e.g.,chlorpromazine ,fluphenazine ,haloperidol ,loxapine ,perphenazine ,pimozide ,pipamperone ,prochlorperazine ,setoperone ,spiperone ,spiramide ,thioridazine ,thiothixene ,trifluoperazine )Volinanserin Xylamidine Yohimbine
5-HT2B
Agonists: 4-Methylaminorex Aminorex Amphetamines (e.g.,chlorphentermine ,cloforex ,dexfenfluramine ,fenfluramine ,levofenfluramine ,norfenfluramine )BW-723C86 DOx (e.g.,DOB ,DOC ,DOI ,DOM )Ergolines (e.g.,cabergoline ,dihydroergocryptine ,dihydroergotamine ,ergotamine ,methylergometrine (methylergonovine) ,methysergide ,pergolide )Lorcaserin MDxx (e.g.,MDA (tenamfetamine) ,MDMA (midomafetamine) ,MDOH ,MMDA )Piperazines (e.g.,TFMPP )PNU-22394 Ro60-0175 Serotonin (5-HT) Tryptamines (e.g.,5-BT ,5-CT ,5-MT ,α-Me-5-HT ,bufotenin ,DET ,DiPT ,DMT ,DPT ,psilocin ,psilocybin ,tryptamine )Antagonists: Agomelatine Atypical antipsychotics (e.g.,amisulpride ,aripiprazole ,asenapine ,brexpiprazole ,cariprazine ,clozapine ,N-desalkylquetiapine (norquetiapine) ,N-desmethylclozapine (norclozapine) ,olanzapine ,pipamperone ,quetiapine ,risperidone ,ziprasidone )Cyproheptadine EGIS-7625 Ergolines (e.g.,amesergide ,bromocriptine ,lisuride ,LY-53857 ,LY-272015 ,mesulergine )Ketanserin LY-393558 mCPP Metadoxine Metitepine (methiothepin) Pirenperone Pizotifen Propranolol PRX-08066 Rauwolscine Ritanserin RS-127445 Sarpogrelate SB-200646 SB-204741 SB-206553 SB-215505 SB-221284 SB-228357 SDZ SER-082 Tegaserod Tetracyclic antidepressants (e.g.,amoxapine ,mianserin ,mirtazapine )Trazodone Typical antipsychotics (e.g.,chlorpromazine )TIK-301 Yohimbine
5-HT2C
Agonists: 2Cs (e.g.,2C-B ,2C-E ,2C-I ,2C-T-2 ,2C-T-7 ,2C-T-21 )5-Methoxytryptamines (5-MeO-DET ,5-MeO-DiPT ,5-MeO-DMT ,5-MeO-DPT ,5-MT )α-Alkyltryptamines (e.g.,5-Cl-αMT ,5-Fl-αMT ,5-MeO-αET ,5-MeO-αMT ,α-Me-5-HT ,αET ,αMT )A-372159 AL-38022A Alstonine ATHX-105 Centhaquine CP-809101 Dimemebfe DOx (e.g.,DOB ,DOC ,DOI ,DOM )Ergolines (e.g.,ALD-52 ,cabergoline ,dihydroergotamine ,ergine (LSA) ,ergotamine ,lisuride ,LA-SS-Az ,LSB ,LSD ,LSD-Pip ,LSH ,LSP ,pergolide )Flumexadol Lorcaserin MDxx (e.g.,MDA (tenamfetamine) ,MDMA (midomafetamine) ,MDOH ,MMDA )MK-212 ORG-12962 ORG-37684 Oxaflozane PHA-57378 Phenethylamines (e.g.,lophophine ,mescaline )Piperazines (e.g.,aripiprazole ,BZP ,mCPP ,quipazine ,TFMPP )PNU-22394 PNU-181731 PRX-00933 (BVT-933; GW-876167) Ro60-0175 Ro60-0213 Serotonin (5-HT) Tryptamines (e.g.,5-BT ,5-CT ,bufotenin ,DET ,DiPT ,DMT ,DPT ,psilocin ,psilocybin ,tryptamine )Vabicaserin VR-1065 WAY-629 WAY-161503 YM-348 Antagonists: Adatanserin Agomelatine Atypical antipsychotics (e.g.,asenapine ,clorotepine ,clozapine ,fluperlapine ,iloperidone ,melperone ,olanzapine ,paliperidone ,quetiapine ,risperidone ,sertindole ,ziprasidone ,zotepine )Captodiame CEPC Cinanserin Cyproheptadine Deramciclane Desmetramadol Dotarizine Eltoprazine Ergolines (e.g.,amesergide ,bromocriptine ,LY-53857 ,LY-215840 ,mesulergine ,metergoline ,methysergide ,sergolexole )Etoperidone Fluoxetine FR260010 Irindalone Ketanserin Ketotifen Latrepirdine (dimebolin) LY03017 Medifoxamine Metitepine (methiothepin) Nefazodone Pirenperone Pizotifen Propranolol Ritanserin RS-102221 S-14671 SB-200646 SB-206553 SB-221284 SB-228357 SB-242084 SB-243213 SB-247853 SDZ SER-082 Seganserin Tedatioxetine Tetracyclic antidepressants (e.g.,amoxapine ,aptazapine ,esmirtazapine ,maprotiline ,mianserin ,mirtazapine )TIK-301 Tramadol Trazodone Tricyclic antidepressants (e.g.,amitriptyline ,nortriptyline )Typical antipsychotics (e.g.,chlorpromazine ,loxapine ,pimozide ,pipamperone ,thioridazine )Xylamidine
5-HT3 –7
5-HT3
Agonists: Alcohols (e.g.,butanol ,ethanol (alcohol) ,trichloroethanol )m-CPBG Phenylbiguanide Piperazines (e.g.,BZP ,mCPP ,quipazine )RS-56812 Serotonin (5-HT) SR-57227 SR-57227A Tryptamines (e.g.,2-Me-5-HT ,5-CT ,bufotenidine (5-HTQ) )Volatiles/gases (e.g.,halothane ,isoflurane ,toluene ,trichloroethane )YM-31636 Antagonists: Alosetron Anpirtoline Arazasetron AS-8112 Atypical antipsychotics (e.g.,clozapine ,olanzapine ,quetiapine )Azasetron Batanopride Bemesetron (MDL-72222) Cilansetron CSP-2503 Dazopride Dolasetron Galanolactone Granisetron Lerisetron Memantine Ondansetron Palonosetron Ramosetron Renzapride Ricasetron Tedatioxetine Tetracyclic antidepressants (e.g.,amoxapine ,mianserin ,mirtazapine )Thujone Tropanserin Tropisetron Typical antipsychotics (e.g.,loxapine )Volatiles/gases (e.g.,nitrous oxide ,sevoflurane ,xenon )Vortioxetine Zacopride Zatosetron
5-HT4
5-HT5A
5-HT6
Agonists: Ergolines (e.g.,dihydroergocryptine ,dihydroergotamine ,ergotamine ,lisuride ,LSD ,mesulergine ,metergoline ,methysergide )Hypidone Serotonin (5-HT) Tryptamines (e.g.,2-Me-5-HT ,5-BT ,5-CT ,5-MT ,Bufotenin ,E-6801 ,E-6837 ,EMD-386088 ,EMDT ,LY-586713 ,N-Me-5-HT ,ST-1936 ,tryptamine )WAY-181187 WAY-208466 Antagonists: ABT-354 Atypical antipsychotics (e.g.,aripiprazole ,asenapine ,clorotepine ,clozapine ,fluperlapine ,iloperidone ,olanzapine ,tiospirone )AVN-101 AVN-211 AVN-322 AVN-397 BGC20-760 BVT-5182 BVT-74316 Cerlapirdine EGIS-12233 GW-742457 Idalopirdine Ketanserin Landipirdine Latrepirdine (dimebolin) Masupirdine Metitepine (methiothepin) MS-245 PRX-07034 PZKKN-94 Ritanserin Ro 04-6790 Ro 63-0563 SB-258585 SB-271046 SB-357134 SB-399885 SB-742457 Tetracyclic antidepressants (e.g.,amoxapine ,mianserin )Tricyclic antidepressants (e.g.,amitriptyline ,clomipramine ,doxepin ,nortriptyline )Typical antipsychotics (e.g.,chlorpromazine ,loxapine )
5-HT7
Antagonists: Atypical antipsychotics (e.g.,amisulpride ,aripiprazole ,asenapine ,brexpiprazole ,clorotepine ,clozapine ,fluperlapine ,olanzapine ,risperidone ,sertindole ,tiospirone ,ziprasidone ,zotepine )Butaclamol DR-4485 EGIS-12233 Ergolines (e.g.,2-Br-LSD (BOL-148) ,amesergide ,bromocriptine ,cabergoline ,dihydroergotamine ,ergotamine ,LY-53857 ,LY-215840 ,mesulergine ,metergoline ,methysergide ,sergolexole )JNJ-18038683 Ketanserin LY-215840 Metitepine (methiothepin) Ritanserin SB-258719 SB-258741 SB-269970 SB-656104 SB-656104A SB-691673 SLV-313 SLV-314 Spiperone SSR-181507 Tetracyclic antidepressants (e.g.,amoxapine ,maprotiline ,mianserin ,mirtazapine )Tricyclic antidepressants (e.g.,amitriptyline ,clomipramine ,imipramine )Typical antipsychotics (e.g.,acetophenazine ,chlorpromazine ,chlorprothixene ,fluphenazine ,loxapine ,pimozide )Vortioxetine
DRAs Tooltip Dopamine releasing agents
NRAs Tooltip Norepinephrine releasing agents
SRAs Tooltip Serotonin releasing agents
Others
TAAR1 Tooltip Trace amine-associated receptor 1
TAAR5 Tooltip Trace amine-associated receptor 5
Notes: (1) TAAR1 activity of ligands varies significantly between species. Some agents that are TAAR1 ligands in some species are not in other species. This navbox includes all TAAR1 ligands regardless of species. (2) See the individual pages for references, as well as the
List of trace amines ,
TAAR , and
TAAR1 pages.
See also: Receptor/signaling modulators
Tryptamines 1-Methyl-DMT (1,N ,N -TMT, 1-TMT) 1-Methyl-T 2-HO-NMT 2-Methyl-DET 2-Methyl-DiPT 2-Methyl-iPALT (ASR-3002) 2,N ,N -TMT (2-methyl-DMT) 3-IAAR 4-Fluoro-DMT 4-Fluoro-T 4-Methyl-DMT 5-Bromo-DMT 5-Bromo-T 5-Chloro-DMT 5-Chloro-T 5-CT 5-Ethyl-DMT 5-Fluoro-DET 5-Fluoro-DMT 5-Fluoro-EPT 5-Fluoro-T 5-Me-MiPT 5-MeS-DMT 5-Methyl-DMT 5-Methyl-T 6-Fluoro-DET 6-Fluoro-DMT 6-Fluoro-T 6-HO-DET 6-HO-DMT 6-HO-T (6-HT) 6-MeO-DMT 6-MeO-T 6-Methyl-DMT 6-Methyl-T 6,7-DHT 7-Chloro-T 7-HO-DMT 7-HO-T (7-HT) 7-MeO-DMT 7-MeO-T 7-Methyl-DMT 7-Methyl-T Acetryptine (5-AT) Almotriptan Benzotript (4-CB-Trp) BGE Bretisilocin (5-fluoro-MET; GM-2505) Convolutindole A (2,4,6-TBr,1,7-DiMeO-DMT) DALT DAT DBT Desformylflustrabromine DET (T-9) DHT DiPT DMT DPT E-6801 E-6837 EB-003 EiPT EPT FGIN-127 FGIN-143 Idalopirdine iPALT (ALiPT; ASR-3003) Lespedamine (1-MeO-DMT) L-694247 MBT McPT MET MiPT MPT MsBT N -Benzyltryptamine (T-NB, NB-T)N -DEAOP-NETN -DEAOP-NMTNAT NBoc-DMT (NB-DMT) NET/NETP NHT NiPT NMT NsBT NtBT PALT (ASR-3004) PiPT Rizatriptan ST-1936 (2-Me-5-Cl-DMT) Sumatriptan TCS-1205 Tryptamine (T; indolylethylamine) Tryptophan (Trp) WAY-181187 Yuremamine Z2876442907 Zolmitriptan 4-Hydroxytryptamines esters /ethers 5-Hydroxy- and5-methoxytryptamines 2-Methyl-5-HT 2-Methyl-5-MeO-DALT 4-HO-5-MeO-T 4-F-5-MeO-DMT 4,5-DHP-DMT 4,5-DHT 4,5-MDO-DMT 4,5-MDO-DiPT 5-BT 5-Ethoxy-DMT 5-HO-DET 5-HO-DiPT 5-HO-DPT 5-HO-MET 5-HO-NiPT 5-HTP (oxitriptan )5-MeO-2-TMT 5-MeO-34MPEMT 5-MeO-7,N ,N -TMT 5-MeO-DALT 5-MeO-DBT 5-MeO-DET 5-MeO-DiPT 5-MeO-DMT (N ,N ,O -TMS;O -methylbufotenine) 5-MeO-DPT 5-MeO-EiPT 5-MeO-EPT 5-MeO-MALT 5-MeO-MET 5-MeO-MiPT 5-MeO-MsBT 5-MeO-NET 5-MeO-NiPT 5-MeO-NMT (O ,N -DMS) 5-MeO-NsBT 5-MeO-PiPT 5-MeO-NBpBrT 5-MeO-T (5-MT; mexamine;O -methylserotonin) 5-MeO-T-NBOMe 5-MeO-T-NB3OMe 5-MTP (cytoguardin) 5-NOT 5-PhO-T (OVT2) 5,6-DHT 5,6-MDO-DiPT 5,6-MDO-DMT 5,6-MDO-MiPT 5,6-MeO-MiPT 5,7-DHT Arachidonoyl serotonin ASR-3001 (5-MeO-iPALT) BAB Benanserin (BAS; SQ-4788) BGC20-761 Bufotenidine (5-HTQ;N ,N ,N -TMS) Bufotenin (5-HO-DMT;N ,N -DMS; mappine) Bufoviridine (5-SO-DMT) CP-132,484 Cqd 280 Cqd 285 Cqdd 280 Donitriptan EMDT (2-Et-5-MeO-DMT) HIOC Indorenate (TR-3369) IS-159 Isamide (N -CA-5-MT) L-741604 MS-245 N -DEAOP-5-MeO-NETN -DEAOP-5-MeO-NMTN -Feruloylserotonin (moschamine)NB-5-MeO-DALT NB-5-MeO-MiPT Norbufotenin (5-HO-NMT; NMS) O -Acetylbufotenine (5-AcO-DMT)O -Pivalylbufotenine (5-t -BuCO-DMT)Psilomethoxin (4-HO-5-MeO-DMT) Psilomethoxybin (4-PO-5-MeO-DMT) Serotonin (5-HT) N -Acetyltryptaminesα-Alkyltryptamines 5-Hydroxy- and 5-alkoxy-α-alkyltryptamines: 1-Pr-5-MeO-AMT 5-Allyloxy-AMT 5-Ethoxy-αMT 5-iPrO-αMT 5-MeO-αET 5-MeO-αMT (α,O -DMS; Alpha-O) α-Methyl-5-HTP α-Methylmelatonin α-Methylserotonin (5-HO-αMT; α-Me-5-HT) α,N ,O -TMS (5-MeO-α,N -DMT) α,N ,N ,O -TeMS (5-MeO-α,N ,N -TMT) AL-37350A (4,5-DHP-αMT) BW-723C86 α-Ketotryptamines Cyclized tryptamines 5-MeO-IsoqT Barettin BML-190 (indomethacin morpholinylamide) Cyclic 3-OHM Ergolines andlysergamides (e.g.,LSD )Harmala alkaloidsβ-carbolines (e.g.,5-methoxyharmalan ,6-MeO-THH ,6-methoxyharmalan ,9-Me-BC ,β-carboline (norharman) ,fenharmane ,harmaline ,harmalol ,harmane ,harmine ,LY-266,097 ,pinoline ,tetrahydroharmine ,tryptoline )Iboga alkaloidsibogaine ,ibogamine ,noribogaine ,tabernanthine )Ibogalogs (e.g.,catharanthalog ,fluorogainalog ,ibogainalog ,ibogaminalog (DM-506) ,LS-22925 ,noribogainalog ,noribogaminalog ,PHA-57378 ,PNU-22394 ,tabernanthalog )Imidazolylindoles (e.g.,AGH-107 ,AGH-192 ,AH-494 )Metralindole Morpholinylethylindoles (e.g.,mor-T ,5-MeO-mor-T )Partial ergolines and lysergamides (e.g.,NDTDI ,RU-27849 ,RU-28251 ,RU-28306 ,FHATHBIN ,LY-178210 ,Bay R 1531 (LY-197206) ,LY-293284 ,10,11-seco-LSD ,10,11-secoergoline (α,N -Pip-T) ,CT-5252 )Pertines (e.g.,alpertine ,milipertine ,oxypertine ,solypertine )Piperidinylethylindoles (e.g.,pip-T ,5-MeO-pip-T ,indolylethylfentanyl )Pyrrolidinylethylindoles (e.g.,pyr-T ,4-HO-pyr-T ,5-MeO-pyr-T ,4-F-5-MeO-pyr-T ,L-760790 )Pyrrolidinylmethylindoles (e.g.,MPMI ,4-HO-MPMI (lucigenol) ,5F-MPMI ,5-MeO-MPMI ,CP-122288 ,CP-135807 ,eletriptan ,MSP-2020 )Tetrahydrocarbazolamines (e.g.,ciclindole ,flucindole ,frovatriptan ,LY-344864 ,ramatroban )Tetrahydropyridinylindoles (e.g.,RS134-49 ,RU-28253 ,NEtPhOH-THPI )Tetrahydropyrroloquinolines (e.g.,bufothionine ,O -methylnordehydrobufoteninedehydrobufotenine )Yohimbans (e.g.,yohimbine ,rauwolscine ,spegatrine ,corynanthine ,ajmalicine ,reserpine ,deserpidine ,rescinnamine )Isotryptamines Related compounds 2-Azapsilocin 4-Aza-5-MeO-DPT 5-Aza-4-MeO-DiPT 5-HIAA 5-HIAL 5-HITCA 5-MIAL 7-Aza-5-MeO-DiPT α-Carboline γ-Carbolines (pyridoindoles) (e.g.,γ-carboline ,alosetron ,gevotroline ,latrepirdine ,lurosetron ,mebhydrolin ,tiflucarbine )Amedalin Benzindopyrine Benzofurans (e.g.,3-APB (1-oxa-AMT) ,5-MeO-DiBF (1-oxa-5-MeO-DiPT) ,BPAP ,3-F-BPAP ,dimemebfe (5-MeO-BFE; 1-oxa-5-MeO-DMT) ,mebfap (5-MeO-3-APB; 1-oxa-5-MeO-AMT) ,MiPBF (1-oxa-MiPT) ,oxa-noribogaine )Benzothiophenes (e.g.,S-DMT (1-thia-DMT) ,3-APBT (1-thia-AMT) )Carmoxirole CT-4436 Daledalin Gramine Histamine Homotryptamines (e.g.,HT ,DMHT )I-32 IAL IN-399 Indazolethylamines (e.g.,AL-34662 ,AL-38022A ,O -methyl-AL-34662VU6067416 ,YM-348 )Indenylethylamines (e.g.,C-DMT (1-carba-DMT) )Indolizinylethylamines (e.g.,TACT908 (2ZEDMA) ,1ZP2MA ,1Z2MAP1O )Indolylaminopropanes (e.g.,1-API ,2-API ,4-API ,5-API (5-IT; PAL-571) ,6-API (6-IT) ,7-API )Iprindole Masupirdine Medmain Molindone Non-tryptaminetriptans (e.g.,avitriptan ,LY-334370 ,naratriptan ) Ondansetron Oxazinopyridoindoles (e.g.,IHCH-8134 )Phenethylamines (e.g.,phenethylamine ,amphetamine )Piperidinylbenzimidazolines (e.g.,benperidol ,timiperone )Piperazinylbenzisothiazoles (e.g.,lurasidone ,perospirone ,tiospirone ,ziprasidone )Piperidinylbenzisoxazoles (e.g.,iloperidone ,milsaperidone ,ocaperidone ,paliperidone ,risperidone )Piperidinylindoles (e.g.,BRL-54443 ,LY-334370 ,naratriptan ,sertindole ,SN-22 )Pirlindole Pyridinylbenzimidazoles (e.g.,droperidol )Pyridinylindoles (e.g.,tepirindole )Pyridopyrroloquinoxalines (e.g.,IHCH-7113 ,IHCH-7079 ,IHCH-7086 ,lumateperone ,deulumateperone ,ITI-1549 )Pyrrolylethylamines (e.g.,2-pyrrolylethylamine (NEA) ,3-pyrrolylethylamine (3-NEA) ,3-pyrrolylpropylamine )Pyrrolopyridinylethylamines (e.g.,WAY-208466 )Quinolinylethylamines (e.g.,mefloquine )Ro60-0213 Selisistat Tetrahydropyridinylindoles (e.g.,EMD-386088 ,LY-367265 ,RU-24,969 )Tetrahydropyridinylpyrrolopyridines (e.g.,(R )-69 (3IQ) ,(R )-70 ,CP-93129 ,CP-94253 )Tetrindole Tipindole Zilpaterol (RU-42173)
